Search
Request a Quote

Fragmentation, End-Repair, A-Tailing and Ligation Enzymes in NGS

In a ligation-based NGS workflow, fragmentation creates the pieces, end repair prepares their termini, A-tailing can make those termini compatible with a selected adapter, and ligation forms the covalent junctions. Each enzyme stage depends on the substrate left by the preceding stage.

A low library yield can therefore originate before the ligase is added. This guide follows the molecular handoffs in a conventional double-stranded DNA library and uses them to organize selection and troubleshooting. The exact sequence depends on the adapter architecture; A-tailing is not required by every library method.

Specify the required product at every handoff

Draw the starting fragment and the intended library molecule before choosing a mixture of enzymes. Identify the strand orientation, terminal groups, overhangs and adapter junctions. The drawing should make clear which molecular feature changes at each stage and which feature must remain intact.

Head and colleagues describe the conventional progression from fragmented DNA through end preparation and adapter attachment. In practice, some preparations combine activities or remove an intermediate cleanup. That changes how the stages are executed, but not the requirement that each downstream reaction receive a compatible substrate.

Use stage-specific evidence when possible. A fragment-size profile demonstrates length distribution, not the presence of a ligatable phosphate. A DNA concentration measurement does not establish that adapters are attached correctly. A library amplification result examines only molecules able to support that amplification.

This distinction also limits troubleshooting shortcuts. More ligase cannot reliably compensate for an incompatible adapter end, and more amplification cannot restore molecules already lost during conversion. Identify the required intermediate before deciding which reagent to change.

The substrate passed to the next reaction
StageIntended changeProperty to preserve or verify
FragmentationGenerate a suitable distribution of DNA fragments.Relevant sequence representation and usable fragment lengths.
End repairCreate the terminal structure required by the chosen route.Correct overhang processing and terminal chemical groups.
A-tailing, when requiredAdd an appropriate 3-prime A extension.Compatibility with the adapter overhang.
LigationCovalently attach compatible DNA ends.Correct adapter-bearing molecules rather than only total DNA.
CleanupRemove unwanted components and byproducts.Recovery of the intended library-size population.
DNA end structures through fragmentation, end repair, A-tailing and compatible adapter ligation.
Fig 1. Each stage must create the substrate required by the next.

Control length without ignoring end structure

Mechanical shearing and enzymatic fragmentation both generate DNA substrates for later conversion, but they should not be assumed to create identical ends or representation. Evaluate the starting material and the complete preparation rather than choosing solely on workflow speed.

For an enzymatic system, fragment distribution can depend on input properties and the reaction environment. Qualify the chosen exposure and stopping conditions using representative samples. A setting developed with intact genomic DNA may over-process material that was already fragmented before preparation.

Measure the distribution rather than only a single average size. A shift toward very short material can change cleanup recovery and the balance between useful inserts and short byproducts. A broad distribution may also behave differently during downstream selection even if its average appears acceptable.

Tanaka and colleagues identified characteristic sequencing artifacts in a tested library method using enzymatic fragmentation. The appropriate lesson is to evaluate artifact behavior in the selected process, especially when interpreting low-frequency variants. It is not evidence that every enzymatic method is unsuitable or that physical fragmentation is inherently artifact-free.

Native DNA ends may themselves carry information. Harkins and colleagues developed a method to characterize terminal structures that standard preparation can erase. If the analytical purpose includes native overhangs or cleavage features, conventional end polishing may conflict with that purpose. Resolve that requirement before optimizing a standard conversion workflow.

Distinguish end polishing from general damage repair

End repair prepares DNA termini for a subsequent reaction. Depending on the substrate and formulation, polymerase activity can fill a recessed 3-prime end opposite a 5-prime overhang, while 3-prime-to-5-prime exonuclease activity can remove a protruding 3-prime end. A kinase can supply a required 5-prime phosphate where it is absent.

These activities are not interchangeable. Polymerase fill-in changes the length of one strand; exonucleolytic trimming removes nucleotides; phosphorylation changes a terminal chemical group. The combination must produce the end structure required by the adapter design without uncontrolled processing of the fragment.

Common end-polishing schemes use activities associated with T4 DNA polymerase, other DNA polymerase preparations and polynucleotide kinase. Commercial mixtures may contain different combinations, so a generic enzyme-family name is insufficient to define their behavior. Review the functions provided and verify the resulting library performance.

End repair does not mean that every damaged base, cross-link or internal lesion has been restored. A separate damage-repair strategy, if used, requires its own evidence and compatibility assessment. Avoid treating a normal fragment profile after end polishing as proof that the DNA is undamaged.

Haile and colleagues investigated chimeric artifacts in FFPE-derived DNA and proposed a mechanism involving abnormal annealing structures that can be extended during library construction. Their findings show that damaged substrate structure can matter during processing. The reported mitigation should not be copied as a universal cleanup step for every sample.

When end preparation and A-tailing are combined, verify how the process moves from polishing to terminal addition. Residual activities that remove or reshape ends can conflict with the desired final structure if their timing is not controlled. A validated combined reaction is a coordinated system, not simply a list of enzymes placed together.

Match the terminal A to the adapter design

A-tailing generally adds a non-templated adenine to a 3-prime end in a library route designed for compatible T-overhang adapters. Clark demonstrated that several polymerases can add nucleotides to blunt duplex ends without template instruction. That biochemical capability underlies terminal-addition strategies, but does not establish uniform tailing for every enzyme preparation.

Select the activity for the intended product. A polymerase's ability to copy a template is not enough to infer its terminal-addition behavior, and proofreading activity can affect whether an added terminal nucleotide remains. The resulting end population must match the ligation design.

Do not confuse an A-tailed insert with a complete library. It still needs the correct adapter junctions and any subsequent processing specified by the architecture. Likewise, a blunt-ligation route should not receive an A-tailing step merely because it is common in another protocol.

Adapter orientation and terminal modifications deserve an explicit review. Identify which end is intended to ligate, whether the necessary phosphate is supplied by insert or adapter at each junction, and which termini are deliberately blocked. The answer comes from the actual adapter design, not from a generic diagram.

If library conversion changes after an adapter substitution, investigate this interface before changing ligase concentration. Different overhangs or modifications can alter the available substrate even when the oligonucleotide sequence appears superficially similar. Document adapter identity alongside enzyme and program information.

Evaluate joining in the context of competing substrates

DNA ligases form a phosphodiester bond between juxtaposed 3-prime hydroxyl and 5-prime phosphate termini. Tabor describes this core requirement and the differing cofactor needs of commonly used ligases. T4 DNA ligase uses ATP; another ligase cannot be substituted solely because it carries the same general enzyme name.

The geometry of the DNA junction matters as well as the chemical groups. Blunt ends, complementary overhangs and mismatched structures are different substrates. Select a ligase system for the intended junction and qualify it in the actual buffer carried forward from previous processing.

Adapter availability should be considered relative to the number of insert molecules. Equal DNA masses with different fragment lengths do not contain equal numbers of ends. This is one reason an adapter condition established on a long-fragment preparation may behave differently with shorter material.

Excess free adapters and incompatible insert ends can shift the balance toward unwanted products. Adapter dimers and other short species may be amplified or consume sequencing capacity if they survive the workflow. Their presence is a diagnostic observation, not proof that the ligase itself is defective.

Cleanup has a competing objective: remove unwanted material while recovering the intended library. A more stringent size selection may reduce short byproducts but also remove useful short inserts. Compare recovery and composition before and after the relevant cleanup when this tradeoff could affect the assay.

Keep residual enzyme activities and buffer carryover in the investigation. Changes in salt, cofactors or carryover volume can alter the next reaction. Do not assume that removing an intermediate cleanup is neutral merely because a combined commercial workflow exists; the integrated chemistry may have been specifically designed for that transition.

Locate the bottleneck with evidence from adjacent stages

Investigate the first observable departure from the expected process. If fragment size is already wrong, downstream ligation optimization addresses the wrong starting condition. If size is appropriate but adapter-bearing recovery is poor, examine terminal compatibility, conversion and cleanup rather than assuming that all input DNA was ligatable.

Where practical, use a defined compatible substrate as a process control for the reaction under investigation. Interpret it alongside representative sample material: a simple control can demonstrate activity while failing to expose a sample-specific structural problem. Include blanks to identify adapter-derived or reagent-associated background.

Use the observation to choose the next comparison
ObservationInterface to investigateUseful evidence
Unexpectedly short fragments before ligationInput and fragmentation exposure.Starting and post-fragmentation distributions.
Acceptable size but low adapter-bearing recoveryEnd preparation, tailing and adapter compatibility.Defined compatible substrate and stage-specific recovery.
Prominent short library speciesAdapter availability and cleanup selection.Insert-free control and pre/post-cleanup profiles.
Normal concentration but abnormal sequence patternsProcessing artifacts or representation loss.Matched input comparisons and read-level investigation.
Loss appears after cleanupSize-selection and recovery conditions.Recovery of relevant fragment classes across that step.

For a change to one enzyme, retain the surrounding configuration initially so that the comparison remains interpretable. Then assess any interface adjustments the new preparation requires. Confirm the final combination using independent preparations and sequencing evidence appropriate to the intended application.

The NGS Library Preparation Enzyme Selection Guide addresses broader choices between architectures and output metrics. For the present workflow, the qualification record should follow the molecular chain: suitable fragments, compatible termini, intended adapter junctions and acceptable recovery. Each link needs evidence; final concentration alone does not establish that the chain worked correctly.

Troubleshooting map linking fragment size, terminal compatibility and adapter-bearing library recovery.
Fig 2. Locate the failed interface before changing enzyme dose.

Sources and further reading

Online Inquiry

For research and industrial use only, not for personal medicinal use.

Submit